Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Actual Use, Label Comprehension Guidances Slated For 2006

This article was originally published in The Tan Sheet

Executive Summary

Guidances under development in 2006 reflect FDA's interest in improving the quality of Rx-to-OTC switch submissions
Advertisement

Related Content

Former Division Of Nonprescription Clinical Evaluation Head Leonard-Segal Talks About OTC Switches Past, Present And Future
Former Division Of Nonprescription Clinical Evaluation Head Leonard-Segal Talks About OTC Switches Past, Present And Future
Interview: Leonard-Segal On OTC Switch Past, Present and Future
FDA Clearance May Thwart Monograph Goal; Ganley Talks Turkey About ONP
NDAC Calls For Predefined Endpoints In Consumer Behavior Trials
NDAC Meeting On Actual-Use Trials Scheduled For September
ONP Has Actual-Use Trial Panel, Rx-To-OTC Switch MaPP In Mind – Ganley
Future Alli Actual Use, Label Comprehension Commitments Likely
Nonprescription Office In Transition Works To Hire Division Heads
Nonprescription Office In Transition Works To Hire Division Heads

Topics

Advertisement
UsernamePublicRestriction

Register

PS099142

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel